Demonstration of robustness and tunability of our text-based hedonometer, and reasoning for choice of a specific metric. by Peter Sheridan Dodds (188891)

“…Lastly, in plot <b>F</b> (which uses plot <b>A</b>'s legend), we show how coverage of words decreases with word rank. …”

Epidural Hydromorphone for Postpartum Pain Management After Vaginal Delivery: A Randomized Clinical Trial by Yixing Lu (19234084)

“…</p><p dir="ltr"><b>Key Points</b></p><p dir="ltr"><b>Question</b></p><p dir="ltr">In women post-vaginal delivery, does the administration of epidural hydromorphone offer superior analgesia and enhance maternal satisfaction relative to a placebo (normal saline)?</p><p><br></p><p dir="ltr"><b>Findings</b></p><p dir="ltr">Epidural hydromorphone demonstrated a statistically significant reduction in postpartum pain scores, a decreased requirement for supplemental analgesics, and enhanced maternal satisfaction. …”

Solution Properties and Practical Limits of Concentrated Electrolytes for Nonaqueous Redox Flow Batteries by Jingjing Zhang (163589)

“…In this study, we show that ion diffusivities and conductivities of ROM-containing electrolytes reach maxima around 0.5 M and decrease significantly at higher concentrations; realistic limits are established for variations of these parameters. …”

Cilostazol inhibits endothelin-induced cytosolic calcium increase and vasoconstiction in mouse femoral arteries. a. by Yoshifumi Kawanabe (308848)

Base-case cost-effectiveness analysis with deterministic sensitivity analysis from a societal perspective. by May Ee Png (627594)

“…</p><p>* Baseline+workdays lost at 0.5 days.</p>†<p> Baseline+workdays lost at 3 days.…”

Telomestatin induces a de-localization of Topo III from TIN2 and TRF1. by Nassima Temime-Smaali (260017)

“…<p>Representative images are of untreated MRC5-V1/YFP-Topo III cells or cells treated for 48 h with 2 µM telomestatin. …”

Significantly associated SNPs with dEBV for height at withers using a mixed-model approach. by Heidi Signer-Hasler (164244)

“…(additive or allelic) test for association between SNP and trait; the Bonferroni-corrected threshold for a 5% genome-wide significance level is p_BONF = 1.31×10⁻⁶.…”

Comparative Proteomic Profiling of 3T3-L1 Adipocyte Differentiation Using SILAC Quantification by Sunkyu Choi (2141545)

“…A search for Chromosome-Centric Human Proteome Project (C-HPP) using neXtprot highlighted one protein with a protein existence uncertain (PE5) and 17 proteins as functionally uncharacterized protein existence 1 (uPE1). …”

Funnel plot with nonparametric trim-and-fill analysis for maxillary first (a) and second (b) molar. by Seyed Mohsen Hasheminia (21702533)

Genes identified by RNA-Seq as SoxR-dependent in stationary phase^a. by Nawar Naseer (622361)

“…a<p>Genes are organized in decreasing order of SoxR-dependence as determined by RNA-Seq.…”

Image_1_Risk Factors of Silicosis Progression: A Retrospective Cohort Study in China.TIF by Hua Quan (12339904)

“…Forced vital capacity decreased after 1-year (241.5 vs. 55.2 mL) and 2-year (328.1 vs. 68.8 mL) follow-up in the two groups (AS vs. non-AS). …”

Effects of Physical Activity Training in Patients with Alzheimer’s Dementia: Results of a Pilot RCT Study by Vjera A. Holthoff (351112)

“…</p><p>Methods</p><p>In an RCT thirty patients (aged 72.4±4.3 years) with AD (MMSE: 20.6±6.5 points) and their family caregivers were allocated to a home-based 12-week PA intervention program or the usual care group. …”

Table_1_Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Dogs With Tumors.XLSX by Jihu Kim (11439451)

“…Dogs with neoplasia and a plasma cfDNA concentration above 1,247.5 μg/L had shorter survival rates than those with levels below this threshold (26.5 vs. 86.1%, respectively, P < 0.05). …”

Table_1_Risk Factors of Silicosis Progression: A Retrospective Cohort Study in China.docx by Hua Quan (12339904)

“…Forced vital capacity decreased after 1-year (241.5 vs. 55.2 mL) and 2-year (328.1 vs. 68.8 mL) follow-up in the two groups (AS vs. non-AS). …”

Use of a Novel Chagas Urine Nanoparticle Test (Chunap) for Diagnosis of Congenital Chagas Disease by Yagahira E. Castro-Sesquen (284439)

“…The nanoparticles concentrate <i>T. cruzi</i> antigens by 100 fold (western blot detection limit decreased from 50 ng/ml to 0.5 ng/ml). The sensitivity of Chunap in a single specimen at one month of age was 91.3% (21/23, 95% CI: 71.92%–98.68%), comparable to PCR in two specimens at 0 and 1 month (91.3%) and significantly higher than microscopy in two specimens (34.8%, 95% CI: 16.42%–57.26%). …”

Vitamin K Supplementation in Postmenopausal Women with Osteopenia (ECKO Trial): A Randomized Controlled Trial by Angela M Cheung (31352)

“…<div><h3>Background</h3><p>Vitamin K has been widely promoted as a supplement for decreasing bone loss in postmenopausal women, but the long-term benefits and potential harms are unknown. …”

Development and functional characterization of a tissue-engineered blood-air barrier model for <i>in vitro</i> applications by Neval Sevinc Ozdemir (22143730)

“…Epithelial and endothelial monolayers demonstrated tight junction formation as shown by ZO-1 and CD31 expression. TEER was measured as 44 ± 5.0 Ω·cm² with a permeability coefficient (P_app) of 2–5 × 10⁻⁶ cm/s against fluorescein.…”

Set-point viral load and the basic reproductive number, , as a function of CTL-mediated killing. by Christian L. Althaus (112118)

“…<p>The left panels depict the behavior when killing is induced with a total rate per day. The viral load decreases sharply for d (A) since falls below one, and the infection is cleared (C). …”

Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial by Eleonora Riccio (451487)

“…Subjects in Paricalcitol experienced a significant monthly increase of Hb levels equal to +0.16 g/dL [95% C.I. 0.10 to +0.22, p<0.001) while in Group Calcitriol, Hb decrease throughout the follow-up with an average monthly rate of -0.10 g/dL (95% C.I.: -0.17 to -0.04, p<0.001). …”

A 10-Year Analysis of the Effects of Media Coverage of Regulatory Warnings on Antidepressant Use in The Netherlands and UK by Juan Francisco Hernandez (135605)

“…A small decrease of −0.6 DDDs/month (−1.2; −0.05) was observed in Dutch SSRI use shortly after 2003–2004. …”